aamc.org does not support this web browser.

Advocacy & Policy

The Association of American Medical Colleges (AAMC) works with policymakers and other leaders to advance policy priorities that strengthen the nation’s health and well-being.

Through policies that affect health care delivery, research, education, health equity, and more, the federal government is a key partner in sustaining the vitality of the nation’s academic medicine ecosystem, which is essential to improving the health of all. Learn more about the AAMC’s priorities for the 118th Congress.

Diverse group of doctors stacking hands in an operating room table.

Statement on Improving Health Through DEI

The AAMC and other health care and medical associations made a statement in support of DEI policies in health care, to help improve our nation’s health.

Learn more

AAMC Policy and Priorities

microscope

Research

AAMC-member institutions endeavor to prepare a diverse medical research workforce and champion an environment where medical discovery can flourish. This strong commitment is key to innovation that benefits patients.

Explore Research Priorities

doctor in a coat

Clinical Care

AAMC-member teaching hospitals and faculty physicians cultivate and provide high-quality health care, especially for complex and vulnerable patients -- many of whom are unable to receive care elsewhere.

Explore Clinical Care Priorities

Doctor talking to mother and son at community outreach program

Investing in Healthier Communities

Academic medical centers serve at the crossroads of community health, health equity, and population health and are actively working to prevent and address persistent public health challenges.

Explore Healthier Communities

two doctors

Workforce

AAMC-member medical schools and teaching hospitals play a crucial role in preparing future physicians who help create a healthier future for all with innovative graduate medical education.

Explore Workforce Priorities

Capitol building, Washington, DC

Washington Highlights

Washington Highlights is a weekly newsletter that provides updates on the latest legislative and regulatory activities affecting academic medicine.

Subscribe to receive weekly Hill and regulatory updates to your inbox.

Subscribe

Find Advocacy & Policy Content

  • Recent
  • Relevance

Filter Results

Date
Custom Date Range
Date format: MM/DD/YYYY
Topic
71 - 80 of 80 results
FDA - Food & Drug Administration
Testimony & Correspondence

The Conjoint Committee on Continuing Education (CCCE), a national coalition of 26 organizations in the professions of medicine, nursing, dentistry, pharmacy, ph

  • July 11, 2017
  • PDF
Testimony & Correspondence

AAMC submitted comments to the Food and Drug Administration (FDA) on their efforts to enhance patient engagement.

  • June 13, 2017
  • PDF
Testimony & Correspondence

AAMC offers comments related to evaluating and reporting on age, race and ethnicity sub-group data in medical device clinical studies.

  • Sept. 14, 2016
  • PDF
Testimony & Correspondence

An educational primer on the regulation of laboratory developed tests (LDTs.)

  • Sept. 14, 2016
  • PDF
Testimony & Correspondence

AAMC Chief Public Policy Officer Atul Grover, M.D., Ph.D.,  Oct. 9 responded to the Food and Drug Administration’s (FDA) request for comments regarding the WHO’

  • Oct. 9, 2015
  • PDF
Washington Highlights

The AAMC May 7 submitted a comment letter, to the Food and Drug Administration (FDA) and a comment letter to Department of Health and Human Services (HHS) Offic

  • May 8, 2015
Testimony & Correspondence

AAMC submitted a letter May 7 to the Food and Drug Administration (FDA) on the draft guidance for industry, clinical investigators, and institutional review boa

  • May 7, 2015
  • PDF
Testimony & Correspondence

The AAMC submit a letter to the FDA regarding areas of public health concern for racial/ethnic minority populations to enhance development of the FDA’s research

  • April 17, 2015
  • PDF
Testimony & Correspondence

AAMC submitted a Feb. 2 comment letter to the Food and Drug Administration (FDA) regarding their draft guidance to regulate laboratory developed tests (LDTs), a

  • Feb. 4, 2015
  • PDF
Washington Highlights

The AAMC submitted comments on a Department of Health and Human Services notice of proposed rulemaking to review existing regulations.

card in hand
The east side of the US Capitol in the early morning.

AAMC Champion of Academic Medicine Award

This award recognizes members of Congress and staff for extraordinary leadership in support of the academic medicine community.

Learn more

Advocacy Coalitions

The Ad Hoc Group for Medical Research supports enhancing the federal investment in the biomedical, behavioral, and population-based research conducted and supported by the NIH.

The GME Advocacy Coalition (GMEAC) is a group of organizations dedicated to the expansion and preservation of Medicare-supported graduate medical education.

The HPNEC advocates for continued support for the health professions and nursing workforce development programs critical to providing continued services to underserved and minority communities.

The FOVA is a diverse coalition representing national academic, medical, and scientific societies; voluntary health and patient advocacy groups; and veteran-focused associations.

Questions for the Office of Government Relations?

Email Us
AAMC Action

AAMC Action – Let’s Raise Our Voices Together

We are a community of students, residents, researchers, faculty members, physicians, and others who advocate on behalf of academic medicine to improve the health of people everywhere.

Join Us